(Q61922819)
Statements
A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Two 14 Day Cycles of Oral Doses of Oleoyl-Estrone (MP-101) in Obese Adult Subjects (English)
0 references
June 2006
0 references
100
0 references
18 year
0 references
65 year
0 references